Correlation Study of PCSK9 and Lp(a) Levels and Coronary Artery Lesions in CHD Patients
Author:
Affiliation:

a) Levels and Coronary Artery Lesions in CHD Patients LI Hong-Yan (The First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [14]
  • | | | |
  • Comments
    Abstract:

    Aim To investigate the correlation between the levels of PCSK9 and Lp(a) and the severity of coronary artery lesions in patients with coronary heart disease(CHD). Methods 114 CHD patients and 78 healthy subjects were randomly selected to detect the severity of coronary artery lesions through coronary arteriography. We further detected the levels of serum TC, TG, HDLC and LDLC by routine method, and detected the levels of serum PCSK9 and Lp(a) via ELISA. Results The levels of serum TC, LDLC, TG, PCSK9 and Lp(a) in CHD groups were increased compared with control group (P<0.05). The levels of serum PCSK9 and Lp(a) had positive correlation with Gensini score and severity of coronary artery lesions. In addition, the levels of serum PCSK9 showed a positive correlation with Lp(a), LDLC and TC in CHD groups, but had no significant relation with HDLC, TG, BMI and age. Conclusion PCSK9 levels were positively associated with Lp(a) levels in CHD patients. Moreover, PCSK9 and Lp(a) were positively correlated with the severity of coronary artery lesions.

    Reference
    [1] Zhao Xue-shan, Peng juan, Wu Qi, et al.Imbalanced cholesterol metabolism in Alzheimer's disease.Clin Chim Acta,2016.pii:S0009-8981(16)30069-9.doi:10.1016/j.cca.2016.02.024.[Epub ahead of print]
    [2] 江璐,龚慧琴,刘录山.前蛋白转化酶PCSK9的生物学功能.中国生物化学与分子生物学报,2010,26(12):1 085-089.
    [3] Kereiakes DJ, Robinson JG, Cannon CP, et al.Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy:The ODYSSEY COMBO I study.Am Heart J, 2015,169(6):906-915.
    [4] Raal FJ, Giugliano RP, Sabatine MS, et al.Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145):a pooled analysis of more than 1,0 patients in 4 phase II trials.J Am Coll Cardiol, 4,3(13):1 278-288.
    [5] Bircan Alan, Veysi Akpolat, Adem Aktan,et al.Relationship between osteopenic syndrome and severity of coronary artery disease detected with coronary angiography and Gensini score in men.Clin Interv Aging, 6,1:377-382.
    [6] 赵伟林,杨帆,员丽培, 等.血清同型半胱氨酸及脂蛋白(a)与冠心病的相关性研究.中国循证心血管医学杂志, 5,7(2):229-231.
    [7] Hopewell JC, Seedorf U, Farrall M, et al.Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.J Intern Med, 4,6(3):260-268.
    [8] Nekaies Y, Baudin B, Kelbousi S, et al.Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients.J Diabetes Complications, 5,9(8):1 165-170.
    [9] Zhu YM, Anderson TJ, Sikdar K, et al.Association of Proprotein Convertase Subtilisin/Kexin Type 9(PCSK9) With Cardiovascular Risk in Primary Prevention.Arterioscler Thromb Vasc Biol, 5,5:2 254-259.
    [10] Werner C, Hoffmann MM, Winkler K, et al.isk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronarydisease on statin treatment.Vascul Pharmacol, 4,2(2):94-102.
    [11] Santos RD.Review:PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemia.Ann Intern Med, 6,4(6):JC31.
    [12] Yang SH, Li S, Zhang Y, et al.Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.J Endocrinol Invest, 2016 [Epub ahead of print]
    [13] Persson L, Henriksson P, Westerlund E, et al.Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women.Arterioscler Thromb Vasc Biol, 2,2(3):810-814.
    [14] Romagnuolo R, Scipione CA, Boffa MB, et al.Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor.J Biol Chem, 5,0(18):1 1649-662.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

LI Hong-Yan. Correlation Study of PCSK9 and Lp(a) Levels and Coronary Artery Lesions in CHD Patients[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(6):607-610.

Copy
Share
Article Metrics
  • Abstract:1024
  • PDF: 391
  • HTML: 0
  • Cited by: 0
History
  • Received:November 23,2015
  • Revised:January 10,2016
  • Online: June 30,2016
Article QR Code